These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 37439132)

  • 1. Targeting the gut microbiota to alleviate chemotherapy-induced toxicity in cancer.
    Xu Y; Du H; Chen Y; Ma C; Zhang Q; Li H; Xie Z; Hong Y
    Crit Rev Microbiol; 2023 Jul; ():1-17. PubMed ID: 37439132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Connecting the dots: Targeting the microbiome in drug toxicity.
    Luo Y; Zhou T
    Med Res Rev; 2022 Jan; 42(1):83-111. PubMed ID: 33856076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota, chemotherapy and the host: the influence of the gut microbiota on cancer treatment.
    Pouncey AL; Scott AJ; Alexander JL; Marchesi J; Kinross J
    Ecancermedicalscience; 2018; 12():868. PubMed ID: 30263059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of gut microbiota and metabolites in cancer chemotherapy.
    Li S; Zhu S; Yu J
    J Adv Res; 2023 Nov; ():. PubMed ID: 38013112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications.
    Zhao LY; Mei JX; Yu G; Lei L; Zhang WH; Liu K; Chen XL; Kołat D; Yang K; Hu JK
    Signal Transduct Target Ther; 2023 May; 8(1):201. PubMed ID: 37179402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota modulation of chemotherapy efficacy and toxicity.
    Alexander JL; Wilson ID; Teare J; Marchesi JR; Nicholson JK; Kinross JM
    Nat Rev Gastroenterol Hepatol; 2017 Jun; 14(6):356-365. PubMed ID: 28270698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal Microbiota: A Novel Target to Improve Anti-Tumor Treatment?
    Villéger R; Lopès A; Carrier G; Veziant J; Billard E; Barnich N; Gagnière J; Vazeille E; Bonnet M
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31533218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutritional Interventions Targeting Gut Microbiota during Cancer Therapies.
    Rinninella E; Raoul P; Cintoni M; Palombaro M; Pulcini G; Gasbarrini A; Mele MC
    Microorganisms; 2021 Jul; 9(7):. PubMed ID: 34361904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting strategies for chemotherapy-induced peripheral neuropathy: does gut microbiota play a role?
    Zhong S; Zhou Z; Liang Y; Cheng X; Li Y; Teng W; Zhao M; Liu C; Guan M; Zhao C
    Crit Rev Microbiol; 2019 Aug; 45(4):369-393. PubMed ID: 31106639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut Microbiota Modulation of Efficacy and Toxicity of Cancer Chemotherapy and Immunotherapy.
    Chrysostomou D; Roberts LA; Marchesi JR; Kinross JM
    Gastroenterology; 2023 Feb; 164(2):198-213. PubMed ID: 36309208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiota-Host-Irinotecan Axis: A New Insight Toward Irinotecan Chemotherapy.
    Yue B; Gao R; Wang Z; Dou W
    Front Cell Infect Microbiol; 2021; 11():710945. PubMed ID: 34722328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut Microbiota Shapes the Efficiency of Cancer Therapy.
    Ma W; Mao Q; Xia W; Dong G; Yu C; Jiang F
    Front Microbiol; 2019; 10():1050. PubMed ID: 31293523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota and cancer: How gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy.
    Gori S; Inno A; Belluomini L; Bocus P; Bisoffi Z; Russo A; Arcaro G
    Crit Rev Oncol Hematol; 2019 Nov; 143():139-147. PubMed ID: 31634731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between gut microbiota and tumour chemotherapy.
    Liu L; Bai Y; Xiang L; Qi W; Gao L; Li X; Li H; Wang B; Chen H
    Clin Transl Oncol; 2022 Dec; 24(12):2330-2341. PubMed ID: 36103048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes.
    Ting NL; Lau HC; Yu J
    Gut; 2022 Jul; 71(7):1412-1425. PubMed ID: 35277453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptors in the pathogenesis of chemotherapy-induced gastrointestinal toxicity.
    Cario E
    Curr Opin Support Palliat Care; 2016 Jun; 10(2):157-64. PubMed ID: 26986508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and toxicity of antineoplastic antimetabolites: Role of gut microbiota.
    Huang X; Chen L; Li Z; Zheng B; Liu N; Fang Q; Jiang J; Rao T; Ouyang D
    Toxicology; 2021 Aug; 460():152858. PubMed ID: 34273448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota, an emergent target to shape the efficiency of cancer therapy.
    Kouidhi S; Zidi O; Belkhiria Z; Rais H; Ayadi A; Ben Ayed F; Mosbah A; Cherif A; El Gaaied ABA
    Explor Target Antitumor Ther; 2023; 4(2):240-265. PubMed ID: 37205307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic Cancer, Gut Microbiota, and Therapeutic Efficacy.
    Zhang X; Liu Q; Liao Q; Zhao Y
    J Cancer; 2020; 11(10):2749-2758. PubMed ID: 32226493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy-induced gastrointestinal toxicity: Pathogenesis and current management.
    He Y; Zheng J; Ye B; Dai Y; Nie K
    Biochem Pharmacol; 2023 Oct; 216():115787. PubMed ID: 37666434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.